Abstract
Accurate prediction of the temporal and spatial characteristics of COVID-19 infection can provide favorable guidance for epidemic prevention and control. We first introduce individual antibody dynamics into an agent-based model. Antibody dynamics model can well explain the antibody fading effects through time. Based on this model, we further developed an agent-based approach which considers the dynamic behaviors of each individual antibodies. The method can effectively reflect the dynamic interaction between the antibody and the virus in each host body in the overall population. Using this method, we can accurately predict the temporal and spatial characteristics of the epidemic. It can quantitatively calculate the number and spatial distribution of infected persons with different symptoms at different times. At the same time, our model can predict the prevention and control effect of different prevention and control measures. At present, China’s dynamic zero strategies mainly include large-scale nucleic acid test, isolation of positive infected persons and their close contacts. Our model demonstrates that for a less infectious and more virulent variant, this approach can achieve good preventive effect. The effect of reducing social contacts and quarantining only positive infected persons is relatively weaker on epidemic control. This can explain why China’s targeted epidemic-control measures had an excellent performance in 2020 and 2021. However, our model also warns that for the highly infectious and less virulent variant, targeted epidemic-control measures can no longer achieve effective control of the epidemic. Therefore, we must choose to quarantine potential infected groups in a wider range (such as the quarantine of secondary close contact and tertiary close contact) or coexist with the virus. Furthermore, our model has a strong traceability ability, which can effectively conduct epidemiological investigation to unearth patient number zero based on the early epidemic distribution. In the end, our model expands the traditional approaches of epidemiological simulation and provides an alternative in epidemic modeling.
Major findings First, a method was developed to integrate the characteristics of individual antibody dynamics into epidemic prediction;
Second, this model can effectively predict the spatiotemporal characteristics of patients with different symptoms (including asymptomatic patients, mild and severe patients, etc.);
Thirdly, this model proves that China’s dynamic zero strategy which include the quarantine of close contact people is more efficient than just isolating positive cases;
Fourth: This model also reflects the limitations of targeted epidemic-control strategies and warns that for the highly infectious and less virulent variant, targeted epidemic-control measures can no longer achieve effective control of the epidemic;
Fifth, this model can help epidemiological research and find out patient zero according to the early incidence of the epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Dezhou University. No 30101418
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
